Diabetes and COVID-19: population impact 18 months into the pandemic
EW Gregg, MK Sophiea, M Weldegiorgis - Diabetes Care, 2021 - diabetesjournals.org
Eighteen months into the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2)(coronavirus disease 2019 [COVID-19]) pandemic, epidemiologic studies indicate that …
2)(coronavirus disease 2019 [COVID-19]) pandemic, epidemiologic studies indicate that …
Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: a meta-analysis of observational studies
M Garofolo, M Aragona, C Rodia, P Falcetta… - diabetes research and …, 2021 - Elsevier
Aims To assess the effects of lockdown due to COVID-19 pandemic on glucose metrics,
measured by glucose monitoring systems, in adult individuals with type 1 diabetes. Methods …
measured by glucose monitoring systems, in adult individuals with type 1 diabetes. Methods …
SARS-CoV-2 initiates programmed cell death in platelets
M Koupenova, HA Corkrey, O Vitseva… - Circulation …, 2021 - Am Heart Assoc
Rationale: Coronavirus disease 2019 (COVID-19) is characterized by increased incidence
of microthrombosis with hyperactive platelets sporadically containing viral RNA. It is unclear …
of microthrombosis with hyperactive platelets sporadically containing viral RNA. It is unclear …
Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource
Objective To describe a novel England-wide electronic health record (EHR) resource
enabling whole population research on covid-19 and cardiovascular disease while ensuring …
enabling whole population research on covid-19 and cardiovascular disease while ensuring …
Relation of incident type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland
PM McKeigue, S McGurnaghan, L Blackbourn… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE Studies using claims databases reported that severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection> 30 days earlier was associated with an …
syndrome coronavirus 2 (SARS-CoV-2) infection> 30 days earlier was associated with an …
[HTML][HTML] Sulodexide in the treatment of patients with early stages of COVID-19: a randomized controlled trial
AJ Gonzalez-Ochoa, JD Raffetto… - Thrombosis and …, 2021 - thieme-connect.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may induce several
vascular endothelial-dependent systemic complications, and sulodexide has pleiotropic …
vascular endothelial-dependent systemic complications, and sulodexide has pleiotropic …
Association between glucagon-like peptide 1 receptor agonist and sodium–glucose cotransporter 2 inhibitor use and COVID-19 outcomes
OBJECTIVE To determine the respective associations of premorbid glucagon-like peptide-1
receptor agonist (GLP1-RA) and sodium–glucose cotransporter 2 inhibitor (SGLT2i) use …
receptor agonist (GLP1-RA) and sodium–glucose cotransporter 2 inhibitor (SGLT2i) use …
Age and hospitalization risk in people with type 1 diabetes and COVID-19: data from the T1D Exchange Surveillance Study
C Demeterco-Berggren, O Ebekozien… - The Journal of …, 2022 - academic.oup.com
Context COVID-19 morbidity and mortality are increased in type 1 diabetes (T1D), but few
data focus on age-based outcomes. Objective This work aimed to quantify the risk for COVID …
data focus on age-based outcomes. Objective This work aimed to quantify the risk for COVID …
A worldwide perspective on COVID-19 and diabetes management in 22,820 children from the SWEET project: diabetic ketoacidosis rates increase and glycemic …
T Danne, S Lanzinger, M de Bock… - Diabetes technology …, 2021 - liebertpub.com
Aims: To investigate the short-term effects of the first wave of COVID-19 on clinical
parameters in children with type 1 diabetes (T1D) from 82 worldwide centers participating in …
parameters in children with type 1 diabetes (T1D) from 82 worldwide centers participating in …
Glycemic control and clinical outcomes in US patients with COVID-19: data from the National COVID Cohort Collaborative (N3C) database
OBJECTIVE The purpose of the study is to evaluate the relationship between HbA1c and
severity of coronavirus disease 2019 (COVID-19) outcomes in patients with type 2 diabetes …
severity of coronavirus disease 2019 (COVID-19) outcomes in patients with type 2 diabetes …